Clinical trials: Gamma Knife Radiosurgery
Brain Metastases, Resection Cavity
Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases
This prospective, randomized, controlled, monocentric clinical phase III study focuses on stereotactic irradiation of resection cavities of brain metastases after surgical resection and seeks to demonstrate the superiority of…
- Trial name
- SATURNUS (NCT05160818)
- Testing
- Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
- Where
- Germany
- Volunteers
- 126 people
- Sponsor
- Technical University of Munich
Acromegaly Due to Pituitary Adenoma
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
In this study, the investigators hypothesize that upfront gamma knife radiosurgery with drug therapy is superior in the treatment of growth hormone-secreting pituitary tumors after primary surgical treatment compared with the…
- Trial name
- MERGE (NCT03439709)
- Testing
- Gamma knife radiosurgery, Lanreotide 60Mg Solution for Injection
- Where
- South Korea
- Volunteers
- 90 people
- Sponsor
- Samsung Medical Center
Parkinson's Disease, With Inclusion Criteria for STN Deep Brain Stimulation
Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation.
The goal of our trial is to evaluate the tolerance and efficacy of the STN radiosurgery in Parkinsonian patients presenting with the inclusion criteria for the STN stimulation but presenting also with clear contraindications to…
- Conditions
- Parkinson's Disease, With Inclusion Criteria for STN Deep Brain Stimulation, Presenting a Contraindication to Intracerebral Electrode Implantati
- Trial name
- NCT01284699
- Testing
- Gamma Knife radiosurgery
- Where
- France
- Volunteers
- 14 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
Brain Micrometastases
RCT of the 4mm vs. the 8mm Collimator for GKR of Brain Micrometastases
Gamma Knife Radiosurgery (GKR) is a well-established treatment modality for brain metastasis (Chiou 2013; Salvetti, Nagaraja et al. 2013).
- Trial name
- NCT02220127
- Testing
- GKR with a single shot of the 8 mm collimator, GKR with a single shot of the 4 mm collimator
- Where
- 3 sites in United Kingdom
- Volunteers
- 298 people
- Sponsor
- University College, London
Gamma Knife Radiosurgery
Gamma Knife Dosimetric Differences, TMR 10 Versus Convolution Algorithm
Gamma Knife Radiosurgery (GKR) is a well established treatment modality for brain tumors and functional disorders of the brain. It relies on mathematical algorithms to predict dose distribution and to calculate the dose at…
- Trial name
- NCT02374983
- Testing
- Gamma knife radiosurgery re-planning with convolution algorithm
- Where
- United Kingdom
- Volunteers
- 100 people
- Sponsor
- University College, London
Vestibular Schwannoma, Hearing Loss
Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study
Patients undergoing cochlear implantation after radio surgery for vestibular schwannoma will be included in the study. Patients will undergo preoperative and intraoperative eABR measurement.
- Trial name
- NCT03745534
- Testing
- eABR
- Where
- Austria
- Volunteers
- 8 people
- Sponsor
- Christoph Arnoldner
Vestibular Schwannoma
Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study
The effect of Gamma knife radiosurgery (GKRS) on hearing loss, in patients with vestibular schwannoma (VS) and preserved hearing is still unclear.
- Trial name
- NCT01938677
- Testing
- Initial Gamma knife radiosurgery
- Where
- Sweden
- Volunteers
- 67 people
- Sponsor
- Karolinska Institutet
Patients With Parkinson's Disease
Evaluation of Bilateral Gamma Knife Thalamotomy in Patients Presenting With Severe Essential Tremor
Essential tremor (ET) is the most frequent movement disorder. Its prevalence is about 1/200 implying that at least 300 000 peoples are concerned in France. Its frequency increase with age (14% of patients 65 yo).
- Trial name
- VIMBIL (NCT02827955)
- Testing
- Gamma Knife® radiosurgery bilateral
- Where
- France
- Volunteers
- 33 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
Glioblastoma, Astrocytoma, Grade III
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Several investigations suggest neural stem cells located in the subventricular region play an active role in promoting or even initiating cortical malignant glioma growth.
- Conditions
- Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, Malignant Glioma
- Trial name
- NCT03956706
- Testing
- Stereotactic Radiosurgery
- Where
- United States
- Sponsor
- Northwell Health
Brain and Central Nervous System Tumors, Metastatic Cancer
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
RATIONALE: Learning about the side effects of stereotactic radiosurgery in patients with brain tumors or other brain disorders may help doctors plan treatment and help patients live more comfortably.
- Conditions
- Brain and Central Nervous System Tumors, Metastatic Cancer, Radiation Toxicity
- Trial name
- NCT00255671
- Testing
- Questionnaire
- Where
- United States
- Volunteers
- 76 people
- Sponsor
- Case Comprehensive Cancer Center
Cerebral Necrosis
Adverse Radiation Effects After Gamma Knife Radio Surgery and Hyperbaric Oxygen Therapy
Evaluation of clinical improvement and the reduction of edema lesion documented by magnetic resonance imaging (MRI) in patients with cerebral radiation necrosis post gamma knife surgery (GKS) by treatment with hyperbaric oxygen…
- Trial name
- GKSHBO (NCT02714465)
- Testing
- hyperbaric oxygen therapy
- Where
- Italy
- Volunteers
- 65 people
- Sponsor
- Niguarda Hospital
Brain Metastases
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Background. Brain metastases are the most common intracranial tumor and occur in 20-40% of all oncological patients. The most common primary cancer in brain metastases is lung cancer, followed by melanoma, breast cancer, renal…
- Trial name
- NCT04042220
- Testing
- Glucocorticoids
- Where
- Austria
- Volunteers
- 200 people
- Sponsor
- Medical University of Vienna
Long Term, Hypopituitarism
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.
- Conditions
- Long Term, Hypopituitarism, Gamma Knife Radiosurgery, Pituitary Adenomas
- Trial name
- NCT07015645
- Testing
- Gamma Knife Radiosurgery
- Where
- Egypt
- Volunteers
- 137 people
- Sponsor
- Al-Azhar University
Parkinsons Disease
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
This is a pilot study to evaluate the safety and efficacy of unilateral gamma knife subthalamotomy for Parkinson's disease in patients deemed poor candidates for deep brain stimulation.
- Trial name
- GKSTN (NCT02249559)
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- NYU Langone Health
Vestibular Schwannoma
Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging
Response Prediction after Gamma Knife Surgery (GKS) in Patients with Vestibular Schwannoma using Dynamic Contrast-Enhanced (DCE) MR Imaging
- Trial name
- NCT03097822
- Volunteers
- 90 people
- Sponsor
- Seoul National University Hospital
Neoplasm Metastases
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
The aim of the study is to assess prospectively the impact of radiosurgery on the quality of life in patients with brain metastases.
- Trial name
- PRAMECE (NCT02565433)
- Testing
- questionnaire administration
- Where
- France
- Volunteers
- 52 people
- Sponsor
- Centre Oscar Lambret
Brain Metastases
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
Gamma Knife radiosurgery is a non-invasive technique for the delivery of a single, high dose of radiation to an intra-cranial target.
- Trial name
- NCT00602992
- Where
- Canada
- Volunteers
- 45 people
- Sponsor
- University Health Network, Toronto
Glioblastoma
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
The purpose of this study is to evaluate the safety and feasibility of the immunotherapeutic agent nivolumab given in combination with gamma knife therapy and valproate in patients with recurrent glioblastoma, a common and lethal…
- Trial name
- NCT02648633
- Testing
- Stereotactic Radiosurgery, Nivolumab, Valproate
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- University of Virginia
Neoplasm Metastases
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
Stereotactic radiosurgery (SRS) is increasingly applied in patients with brain metastases (BM) and is expected to have less adverse effects on cognitive functioning than Whole Brain Radiation Therapy (WBRT).
- Trial name
- NCT02953756
- Testing
- Gamma Knife radiosurgery
- Where
- Netherlands
- Volunteers
- 92 people
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
Severe Disabling Tremor
Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor.
Gamma-Knife radiosurgery of the VIM for patients presenting with severe drug-resistant tremor is now current practice as an alternative to Deep Brain Stimulation (DBS) of the VIM.
- Trial name
- GARP (NCT03350139)
- Testing
- gamma knife radiosurgery
- Where
- France
- Volunteers
- 700 people
- Sponsor
- Assistance Publique Hopitaux De Marseille